CLPT Logo

ClearPoint Neuro, Inc. (CLPT) 

NASDAQ
Market Cap
$433.22M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
603 of 959
Rank in Industry
72 of 120

Largest Insider Buys in Sector

CLPT Stock Price History Chart

CLPT Stock Performance

About ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration …

Insider Activity of ClearPoint Neuro, Inc.

Over the last 12 months, insiders at ClearPoint Neuro, Inc. have bought $0 and sold $0 worth of ClearPoint Neuro, Inc. stock.

On average, over the past 5 years, insiders at ClearPoint Neuro, Inc. have bought $0 and sold $554,758 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 25,000 shares for transaction amount of $31,250 was made by BURNETT JOSEPH MICHAEL (President and CEO) on 2018‑09‑25.

List of Insider Buy and Sell Transactions, ClearPoint Neuro, Inc.

2022-08-15SaleCEO and President
18,867
0.0889%
$16.07$303,193-43.20%
2021-11-11SaleCEO and President
10,000
0.0495%
$16.88$168,800-36.25%
2021-09-21SaleCEO and President
9,637
0.0508%
$17.98$173,273-37.50%
2021-06-21SaleCEO and President
25,000
0.1361%
$18.57$464,250-37.48%
2018-09-25PurchasePresident and CEO
25,000
0.0092%
$1.25$31,250+74.16%
2018-08-24PurchasePresident and CEO
7,500
0.0035%
$1.58$11,850+87.01%
2018-08-22PurchasePresident and CEO
4,637
0.0021%
$1.55$7,187+78.13%
2018-05-21PurchasePresident and CEO
7,500
0.0052%
$2.39$17,903-12.50%
2017-05-26PurchaseCHIEF EXECUTIVE OFFICER
12,500
0.0073%
$2.00$25,000-14.06%
2017-05-26Purchasedirector
7,500
0.0044%
$2.00$15,000-14.06%
2016-09-02PurchaseCHIEF EXECUTIVE OFFICER
20,000
0.0293%
$5.00$100,000-39.86%
2016-09-02Purchasedirector
10,000
0.0147%
$5.00$50,000-39.86%
2015-12-18Purchasedirector
154,035
0.0147%
$0.32$50,000-42.50%
2015-12-18Purchasedirector
154,035
0.0147%
$0.32$50,000-42.50%
2015-12-18PurchaseCHIEF EXECUTIVE OFFICER/PRES
308,071
0.0293%
$0.32$100,000-42.50%
2015-12-18Purchasedirector
77,017
0.0073%
$0.32$25,000-42.50%
2014-12-24Purchasedirector
23,310
0.0044%
$0.64$15,000-8.79%
2014-09-12Purchasedirector
16,000
0.0055%
$1.18$18,880-11.61%
2014-08-13Purchasedirector
3,500
0.001%
$1.00$3,5000.00%
2014-06-13Purchase
30,000
0.0064%
$0.73$21,900+36.99%

Insider Historical Profitability

<0.0001%
KOOB CHARLES Edirector
736931
2.6715%
$15.7110
PIETRANGELO MICHAELdirector
451296
1.636%
$15.7170+2.54%
Malernee James K. Jr.director
290659
1.0537%
$15.7120<0.0001%
BURNETT JOSEPH MICHAELCEO and President
262095
0.9501%
$15.7144+56.7%
Richards Timothy T.director
110005
0.3988%
$15.7110

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.